Potential antiviral effects of the marine probiotic Paraliobacillus zengyii on the respiratory syncytial virus

Cód QR

Potential antiviral effects of the marine probiotic Paraliobacillus zengyii on the respiratory syncytial virus

Abstract Probiotics can reduce the incidence of respiratory syncytial virus (RSV) disease in premature infants; this approach is resource‐intensive and less expensive than other strategies and easier to implement than most current methods worldwide. Traditional lactic acid‐producing bacteria are the...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Qianjin Fan, Beijie Li, Lan Chen, Mengqi Jiao, Zhijie Cao, Kun Yue, Haoyue Huangfu, Hui Sun, Xiaoxia Wang, Xuelian Luo, Jianguo Xu
Formáid:	Alt
Teanga:	Béarla
Foilsithe / Cruthaithe:	Wiley 2025-06-01
Sraith:	mLife
Ábhair:	antiviral activity marine probiotics Paraliobacillus zengyii respiratory syncytial virus type I interferon
Rochtain ar líne:	https://doi.org/10.1002/mlf2.70015
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Lactobacillus rhamnosus D3189 modulates antiviral and inflammatory responses in primary nasal epithelial cells, reducing respiratory syncytial virus shedding
de réir: Tejasri Yarlagadda, et al.
Foilsithe / Cruthaithe: (2025-07-01)

The promise and progress of RNA-interference-based antiviral therapy for respiratory syncytial virus.
de réir: V. V. Vysochinskayа, et al.
Foilsithe / Cruthaithe: (2014-09-01)

Evaluation of Antiviral Activity of Polymer Electrolytes Encapsulated in Micron Calcium Carbonate
de réir: A. M. Klabukov, et al.
Foilsithe / Cruthaithe: (2025-04-01)

Evaluation of the Antiviral Activity of Drugs from the Group of Polymer Electrolyte Derivatives against a Wide Range of Viruses
de réir: D. N. Razgulyaeva, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Iron metabolism in chronic hepatitis C patients on antiviral treatment
de réir: K. V. Zhdanov, et al.
Foilsithe / Cruthaithe: (2014-09-01)

CLINICAL AND PATHOMORPHOLOGICAL MANIFESTATIONS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION. CASE REPORT
de réir: I. V. Babachenko, et al.
Foilsithe / Cruthaithe: (2018-04-01)

Generation of nanobodies against the F protein of respiratory syncytial virus and establishment of an indirect immunofluorescence assay
de réir: Qianqian Wang, et al.
Foilsithe / Cruthaithe: (2025-07-01)

Interferon Lambda: The Next Frontier in Antiviral Therapy?
de réir: Sofia Chronopoulou, et al.
Foilsithe / Cruthaithe: (2025-05-01)

Epidemiological and Clinical Characteristics of Respiratory Syncytial Virus Infection in Children in Hangzhou (2022–2023)
de réir: Qin-Rui Lai, et al.
Foilsithe / Cruthaithe: (2025-06-01)

Study of the Mechanism of Antiviral Activity of Cytovir®-3 Against Respiratory Viruses <i>In Vitro</i>
de réir: V. V. Zarubaev, et al.
Foilsithe / Cruthaithe: (2023-07-01)

THE EFFICACY OF THE COSTS ON SEVERE RESPIRATORY SYNCYTIAL INFECTION PREVENTION WITH PALIVIZUMAB IN PRETERM INFANTS
de réir: A. V. Rudakova, et al.
Foilsithe / Cruthaithe: (2012-07-01)

ACTIVATION OF SYNTHESIS OF ENDOGENOUS INTERFERON (REVIEW)
de réir: V. V. Poloskov, et al.
Foilsithe / Cruthaithe: (2019-01-01)

Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy
de réir: Seby R, et al.
Foilsithe / Cruthaithe: (2025-07-01)

RNA interference is the basis of human antiviral defense
de réir: J. N. Muratkhodjaev, et al.
Foilsithe / Cruthaithe: (2022-11-01)

Research hotspots and global trends in respiratory syncytial virus over past five years
de réir: Xiaoli Tao, et al.
Foilsithe / Cruthaithe: (2025-08-01)

Current status of developments in the field of respiratory syncytial virus vaccines
de réir: Tatiana S. Kotomina
Foilsithe / Cruthaithe: (2025-05-01)

Burden of respiratory syncytial virus disease in infants and the potential value of maternal immunization in Greece
de réir: George Gourzoulidis, et al.
Foilsithe / Cruthaithe: (2025-07-01)

Respiratory Syncytial Virus Infection. Pathogenesis Peculiarities, Prevention and Treatment Strategies
de réir: V. Z. Krivitskaya
Foilsithe / Cruthaithe: (2013-03-01)

Clinical significance of anaemia in chronic hepatitis c on the combined antiviral therapy with pegylated
de réir: K. V. Zhdanov, et al.
Foilsithe / Cruthaithe: (2014-09-01)

Immunoprophylaxis of Respiratory Syncytial Virus Infection in Children
de réir: A. A. Baranov, et al.
Foilsithe / Cruthaithe: (2015-12-01)

Present State of in vitro and in vivo Studies on Efficacy of Medical Nonspecific Protective Agents with Respect to Genotype IV Coronavirus Causing Severe Acute Respiratory Syndrome
de réir: V. N. Shchukina, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Interferons lambda – therapeutic application
de réir: N. A. Kikhtenko, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Antiviral compounds from plants /
de réir: Hudson, James B.
Foilsithe / Cruthaithe: (1989)

The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
de réir: E. V. Yani, et al.
Foilsithe / Cruthaithe: (2023-03-01)

The Use of Interferon Inducers in an Infectious Disease Clinic
de réir: A. A. Shuldyakov, et al.
Foilsithe / Cruthaithe: (2020-05-01)

IMMUNOPTOPHYLAXIS OF THE RESPIRATORY SYNCYTIAL VIRAL INFECTION IN CHILDREN UNDER RISK OF HEAVY COURSE OF THE DISEASE: PRELIMINARY RESULTS OF IMPLEMENTING THE MOSCOW PROGRAM
de réir: A. A. Korsunskiy, et al.
Foilsithe / Cruthaithe: (2012-06-01)

Progress in the development and use of antiviral drugs and interferon: report of a WHO Scientific Group /
de réir: WHO Scientific Group
Foilsithe / Cruthaithe: (1987)

Characterisation of the respiratory syncytial virus seasonality and its environmental factors in the Americas—a multi-country observational study using routine surveillance networksResearch in context
de réir: Paula Couto, et al.
Foilsithe / Cruthaithe: (2025-08-01)

Hospitalisation trends of respiratory syncytial virus (RSV) infection in adults, six European countries, before and during COVID-19, 2016 to 2023
de réir: on behalf of the PROMISE investigators
Foilsithe / Cruthaithe: (2025-06-01)

Respiratory syncytial virus immunization in children: The old, the new and what’s just around the corner
de réir: Bosco A. Paes, et al.
Foilsithe / Cruthaithe: (2025-12-01)

Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)
de réir: A. V. Chzhao, et al.
Foilsithe / Cruthaithe: (2018-08-01)

Antiviral Properties of Basidiomycetes Metabolites
de réir: A. V. Avtonomova, et al.
Foilsithe / Cruthaithe: (2020-05-01)

Characteristics of respiratory syncytial virus infection in children in Pudong New Area， Shanghai， 2013‒2023
de réir: YU Qiumiao, et al.
Foilsithe / Cruthaithe: (2025-05-01)

Antiviral properties of composition drugs based on double-stranded RNA and human interferon alpha-2b
de réir: S. G. Gamaley, et al.
Foilsithe / Cruthaithe: (2025-02-01)

Virus Infections and Interferon Inductors in the Complex Therapy
de réir: M. G. Romantsov, et al.
Foilsithe / Cruthaithe: (2020-05-01)

INTERFERONS AND EYE DISEASES
de réir: N. A. Kikhtenko, et al.
Foilsithe / Cruthaithe: (2019-06-01)

IMMUNOPROPHYLAXIS OF SEVERE RESPIRATORY-SYNCYTIAL VIRAL INFECTION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA: RESULTS OF 4 EPIDEMIC SEASONS
de réir: A. A. Baranov, et al.
Foilsithe / Cruthaithe: (2012-12-01)

Assessment of efficiency and safety of complex therapy of acute adenoviral diseases in young people
de réir: N. A. Malyshev, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Application of probiotics in gastroenterology
de réir: M. V. Mayevskaya
Foilsithe / Cruthaithe: (2009-12-01)

PROBIOTICS REVISITED: NEW STRAINS, NEW BENEFITS, NEW OPPORTUNITIES
de réir: James Dekker, et al.
Foilsithe / Cruthaithe: (2012-04-01)